The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study aims to see if patient quality of life can be approved after treatment with an
injectable medication called ustekinumab for the treatment of generalized psoriasis. The
investigators hypothesize that the investigators will see improvement in quality of life.